Reta side effects in women commonly include nausea, fatigue, and appetite changes. Here's what early trials report and when to call your doctor.
The most commonly reported reta side effects in women are gastrointestinal: nausea, diarrhea, vomiting, and constipation, often along with reduced appetite and fatigue. Most of these effects are described as mild to moderate and tend to fade as the body adjusts to a new dose. Retatrutide, often shortened to reta, is still an investigational drug, so its long-term safety profile in women is not yet fully known.
What Is Reta, and Why Are So Many Women Asking About It?
Retatrutide is an experimental injectable medication that activates three hormone receptors at once: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes and is given as a once-weekly shot in clinical trials.
Retatrutide is not approved by the FDA for human use in the United States. That means any product sold online under this name is unregulated and unverified, with no guaranteed dose, purity, or safety monitoring.
Interest from women is high because early results showed large average weight loss. Phase 2 data published in the New England Journal of Medicine in 2023 reported average weight reduction of roughly 24% at the highest dose over 48 weeks. That level of results is unusual, and it is the main reason searches for the reta peptide side effects women experience have climbed so quickly.
The Most Common Reta Side Effects Women Report
In the phase 2 obesity trial, gastrointestinal complaints dominated the side effect list. Nausea was the most frequently reported side effect, and it was usually worst during the weeks right after a dose increase.
| Side effect | How common | What usually helps |
|---|---|---|
| Nausea | Most frequently reported effect | Smaller meals, bland foods, slower eating |
| Diarrhea | Common | Fluids, electrolytes, fewer fried or greasy meals |
| Vomiting | Common at higher doses | Hydration; medical care if it lasts more than a day |
| Constipation | Common | Fiber, water, movement, stool softeners |
| Reduced appetite | Expected effect | Protein-forward meals; do not skip eating entirely |
| Fatigue | Common | Sleep, hydration, lab work for iron and B12 |
| Injection-site reactions | Common | Rotate sites, use a room-temperature pen |
| Resting heart rate increase | Less common | Limit caffeine, monitor pulse, report palpitations |
| Dysesthesia (skin sensitivity) | Mostly at higher doses | Often eases after a dose reduction; report it |
Researchers reported that side effects were the main reason some participants stopped treatment, and dropout rates rose at the highest doses. This is a normal pattern for GLP-1 class drugs, but it is worth knowing before starting.
Dose-Related Effects to Watch For
Some reta side effects are clearly tied to dose size rather than to the drug itself. They are more likely during rapid titration or at the top of the dose range.
- Skin sensitivity and tingling: unusual sensations in the hands, feet, or skin were reported mostly at higher doses in the phase 2 trial.
- Heart rate changes: small increases in resting heart rate are documented with this drug class and deserve monitoring.
- Gallbladder problems: gallstones and gallbladder inflammation are a known risk with rapid weight loss and with GLP-1 medications generally.
- Lean muscle loss: a large share of total weight lost can come from muscle without adequate protein and resistance training.
- Hair shedding: temporary thinning is sometimes reported after fast, substantial weight loss.
Women-Specific Considerations: Pregnancy, Periods, and Fertility
Pregnancy is an exclusion criterion for retatrutide trials, and the drug is not considered safe during pregnancy. Women of childbearing potential enrolled in the studies were typically required to use contraception.
There is no official guidance on breastfeeding because the drug has no approved label. Most clinicians advise against using any investigational GLP-1 drug while nursing.
Menstrual changes are not listed among the reported retatrutide side effects side effects in trial publications. However, rapid weight loss from any cause can shift cycle timing, and improved insulin sensitivity sometimes restores ovulation in women with obesity-related infertility.
No published trial has reported retatrutide side effect rates separately for women and men. Some studies of older GLP-1 medications found higher rates of nausea and injection-site reactions in women, which is one reason women ask about this drug specifically.
How Reta Compares With Other Peptides Women Ask About
Many women research several injectables at the same time. Direct comparison is difficult because most of these products are sold without approval or standardized dosing, and evidence quality varies widely.
| Product | Typical reported side effects | Regulatory status |
|---|---|---|
| Retatrutide | Nausea, diarrhea, vomiting, constipation, skin sensitivity | Investigational; not FDA-approved |
| AOD-9604 | Generally described as mild: injection-site irritation, headache | Not FDA-approved |
| Lipo-C injections | Injection-site pain, digestive upset, allergic reactions | Not FDA-approved as a fat-loss drug |
| PT-141 (bremelanotide) | Flushing, nausea, headache, blood pressure changes | FDA-approved for premenopausal women with HSDD |
| CJC-1295 | Injection-site reactions, flushing, water retention | Not FDA-approved |
| L-carnitine | Stomach upset, fishy body odor at high doses | Sold as a supplement |
Anyone weighing options may also read about aod-9604 benefits and side effects, which are usually described as milder but rest on much weaker evidence than retatrutide trials.
Lipo-C products are marketed for fat loss, and reports of lipo-c shot side effects include injection-site pain, digestive upset, and allergic reactions. People comparing appetite drugs with libido drugs often search pt-141 for women side effects and find flushing, nausea, and headache described most often.
Everyday supplements come up too. Common l-carnitine side effects include stomach upset and a fishy body odor at high doses, while cjc 1295 long-term side effects remain poorly characterized because few long-term human studies exist.
Practical Steps That Lower the Risk of Side Effects
- Start at the lowest dose and increase slowly, only as tolerated.
- Eat smaller meals and stop before you feel full.
- Keep protein high and add resistance training to protect muscle.
- Drink water throughout the day and replace electrolytes if diarrhea occurs.
- Limit fried, greasy, and very spicy foods during dose increases.
- Avoid heavy alcohol, which worsens nausea and dehydration.
- Track symptoms in a simple log so a clinician can spot patterns.
- Use only pharmacy-verified products under medical supervision, never gray-market vials.
When to Contact a Healthcare Professional
Anyone taking or considering retatrutide should discuss side effects with a licensed healthcare professional before starting. Retatrutide is not approved by the FDA, so no clinician can prescribe it through normal channels today.
Seek medical care for severe or persistent vomiting, intense abdominal pain, signs of dehydration, heart palpitations, or skin symptoms that interfere with daily life. Any suspected pregnancy while using a GLP-1 type drug should be reported to a doctor right away.
Frequently Asked Questions
Does reta cause worse side effects in women than in men?
Published retatrutide trial data has not been broken down by sex, so there is no clear answer yet. Some studies of older GLP-1 medications found higher rates of nausea and injection-site reactions in women, so it is a reasonable question to raise with a clinician. Side effect rates also depend heavily on dose and how quickly the dose is increased.
How long do reta side effects last?
Gastrointestinal effects such as nausea and diarrhea usually peak in the first week or two after a dose increase and then ease within a few weeks. Constipation and reduced appetite can persist for as long as the drug is used. Side effects that are severe or getting worse rather than better should be evaluated by a doctor.
Can you take reta while pregnant or breastfeeding?
Retatrutide is investigational and not approved for human use, and pregnancy was an exclusion criterion in its trials. Women of childbearing potential in those studies were typically required to use contraception. There is no safety data on breastfeeding, so most clinicians advise against using any investigational GLP-1 drug while nursing.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.